These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 32657551)

  • 1. Paroxysmal atrial fibrillation is associated with early coagulation activity regardless of risk factors for embolism.
    Negreva MN; Prodanova KS; Vitlianova KD
    Minerva Cardiol Angiol; 2021 Jun; 69(3):269-276. PubMed ID: 32657551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paroxysmal atrial fibrillation: changes in factor VIII and von Willebrand factor impose early hypercoagulability.
    Negreva MN; Prodanova K; Vitlianova K; Madjova C
    Arch Med Sci Atheroscler Dis; 2020; 5():e140-e147. PubMed ID: 32832713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial fibrillation and hypercoagulability: dependent on clinical factors or/and on genetic alterations?
    Hatzinikolaou-Kotsakou E; Kartasis Z; Tziakas D; Hotidis A; Stakos D; Tsatalas K; Bourikas G; Kotsakou ME; Hatseras DI
    J Thromb Thrombolysis; 2003 Dec; 16(3):155-61. PubMed ID: 15087601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paroxysmal Atrial Fibrillation: An Independent Risk Factor for Prothrombotic Conditions.
    Negreva M; Prodanova K; Zarkova A
    J Atr Fibrillation; 2020 Aug; 13(2):2297. PubMed ID: 34950291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of Stroke or Systemic Embolism in Paroxysmal Versus Sustained Atrial Fibrillation: The Fushimi Atrial Fibrillation Registry.
    Takabayashi K; Hamatani Y; Yamashita Y; Takagi D; Unoki T; Ishii M; Iguchi M; Masunaga N; Ogawa H; Esato M; Chun YH; Tsuji H; Wada H; Hasegawa K; Abe M; Lip GY; Akao M
    Stroke; 2015 Dec; 46(12):3354-61. PubMed ID: 26514188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypercoagulability in atrial fibrillation and its relationship with risk factors for systemic embolism].
    Pérez LA; Corbalán R; Acevedo M; Pereira J; Braun S; Tapia J; Kramer A; Lira MT; Huete I; Sepúlveda G; Springmüller D
    Rev Med Chil; 2002 Oct; 130(10):1087-94. PubMed ID: 12491825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paroxysmal Atrial Fibrillation: Insight Into the Intimate Mechanisms of Coagulation.
    Negreva M; Zarkova A; Prodanova K; Petrov P
    Cardiol Res; 2020 Feb; 11(1):22-32. PubMed ID: 32095193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Changes in the Antithrombin and Thrombin-Antithrombin Complex in Patients With Paroxysmal Atrial Fibrillation.
    Negreva M; Georgiev S; Prodanova K; Nikolova J
    Cardiol Res; 2016 Jun; 7(3):89-94. PubMed ID: 28197274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Impact of Asymptomatic Presentation Status in Patients With Paroxysmal and Sustained Atrial Fibrillation: The Fushimi AF Registry.
    Esato M; Chun YH; An Y; Ogawa H; Wada H; Hasegawa K; Tsuji H; Abe M; Lip GYH; Akao M
    Chest; 2017 Dec; 152(6):1266-1275. PubMed ID: 28823813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial fibrillation activates platelets and coagulation in a time-dependent manner: a study in patients with paroxysmal atrial fibrillation.
    Sohara H; Amitani S; Kurose M; Miyahara K
    J Am Coll Cardiol; 1997 Jan; 29(1):106-12. PubMed ID: 8996302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased Activity of the Protein C Anticoagulant Pathway in the Early Hours of Paroxysmal Atrial Fibrillation.
    Negreva M; Georgiev S; Vitlianova K
    Clin Appl Thromb Hemost; 2017 Oct; 23(7):793-799. PubMed ID: 27313201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of paroxysmal atrial fibrillation in a population assessed by continuous 24-hour monitoring.
    Primo J; Gonçalves H; Macedo A; Russo P; Monteiro T; Guimarães J; Costa O
    Rev Port Cardiol; 2017; 36(7-8):535-546. PubMed ID: 28709762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the relationship between death and CHA2DS2-VASc score in peripheral artery disease.
    Yalim Z; Aldemir M; Yalim SA
    Int Angiol; 2020 Dec; 39(6):509-516. PubMed ID: 33140626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doppler-derived indexes and B-type natriuretic peptide in prediction of paroxysmal atrial fibrillation in essential hypertension: a prospective study.
    Badran HM; Eid MA; Michael A
    Echocardiography; 2007 Oct; 24(9):911-22. PubMed ID: 17894569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prothrombotic State in Atrial Fibrillation Patients With One Additional Risk Factor of the CHA
    Głowicki B; Matusik PT; Plens K; Undas A
    Can J Cardiol; 2019 May; 35(5):634-643. PubMed ID: 30955928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHADS(2) and CHA(2)DS (2)-VASc score of patients with atrial fibrillation or flutter and newly detected left atrial thrombus.
    Wasmer K; Köbe J; Dechering D; Milberg P; Pott C; Vogler J; Stypmann J; Waltenberger J; Mönnig G; Breithardt G; Eckardt L
    Clin Res Cardiol; 2013 Feb; 102(2):139-44. PubMed ID: 22983022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with paroxysmal atrial fibrillation but not paroxysmal supraventricular tachycardia display evidence of platelet activation during arrhythmia.
    Atalar E; Haznedaroglu IC; Acil T; Ozer N; Kilic H; Ovunc K; Aksoyek S; Nazli N; Kes S; Kabakçi G; Kirazli S; Ozmen F
    Platelets; 2003; 14(7-8):407-11. PubMed ID: 14713509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of left atrial size and function on P-wave dispersion: a study in patients with paroxysmal atrial fibrillation.
    Tükek T; Akkaya V; Atilgan D; Demirel E; Ozcan M; Güven O; Korkut F
    Clin Cardiol; 2001 Oct; 24(10):676-80. PubMed ID: 11596617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts.
    Piccini JP; Stevens SR; Chang Y; Singer DE; Lokhnygina Y; Go AS; Patel MR; Mahaffey KW; Halperin JL; Breithardt G; Hankey GJ; Hacke W; Becker RC; Nessel CC; Fox KA; Califf RM;
    Circulation; 2013 Jan; 127(2):224-32. PubMed ID: 23212720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Relationship Between Prolidase Activity and Atrial Electromechanical Changes in Patients with Paroxysmal Atrial Fibrillation.
    Tascanov MB
    Comb Chem High Throughput Screen; 2019; 22(1):69-75. PubMed ID: 30843482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.